MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
147 hedge funds and large institutions have $1.42B invested in Momenta Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 82 increasing their positions, 29 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
44% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 25
Holders
147
Holding in Top 10
1
Calls
$834K
Puts
$1.05M
Top Buyers
| 1 | +$20.2M | |
| 2 | +$9.57M | |
| 3 | +$8.61M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$8.28M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.5M |
Top Sellers
| 1 | -$6.54M | |
| 2 | -$3.86M | |
| 3 | -$3.09M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$3.05M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$2.5M |